News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Session R.A. II
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Sold 80,528 shares
@ $0.7082, valued at
$57k
Sold 5,344 shares
@ $0.7, valued at
$3.7k
|
|
| 03/08/2023 |
4
| Session R.A. II (10% Owner) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Acquired 251,296 shares
@ $0
Disposed/sold 199,500 options to buy
@ $1.95, valued at
$389k
|
|
| 12/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 217,850 options to buy
@ $5.96, valued at
$1.3M
|
|
| 12/08/2021 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 16,510 shares
@ $12.12, valued at
$200.1k
Bought 26,008 shares
@ $12.65, valued at
$329k
|
|
| 01/20/2021 |
4
| Session R.A. II (President and CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 199,700 options to buy
@ $31, valued at
$6.2M
|
|
| 05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2018 |
4
| Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 1,667 shares
@ $0
Granted 6,572 options to buy
@ $133.8, valued at
$879.3k
|
|
| 05/12/2017 |
4
| Session R.A. II (Sr. VP, Corp Strategy) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 1,282 options to buy
@ $77.24, valued at
$99k
|
|
| 03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|